Comparison Between Laparoscopic and Robotic Surgery in Elderly Patients With Endometrial Cancer: A Retrospective Multicentric Study.

elderly patients endometrial cancer laparoscopic surgery (LS) minimally invasive surgery (MIS) robotic surgery

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2021
Historique:
received: 14 06 2021
accepted: 06 09 2021
entrez: 11 10 2021
pubmed: 12 10 2021
medline: 12 10 2021
Statut: epublish

Résumé

Elderly endometrial cancer (EEC) patients represent a challenging clinical situation because of the increasing number of clinical morbidities. In this setting of patients, minimally invasive surgery (MIS) has been shown to improve surgical and clinical outcomes. The aim of this study was to evaluate the peri-operative and oncological outcomes of EEC patients who had undergone laparoscopic (LS) or robotic surgery (RS). This is a retrospective multi-institutional study in which endometrial cancer patients of 70 years or older who had undergone MIS for EC from April 2002 to October 2018 were considered. Owing to the non-randomized nature of the study design and the possible allocation biases arising from the retrospective comparison between LS and RS groups, we also performed a propensity score-matched analysis (PSMA). A total of 537 patients with EC were included in the study: 346 who underwent LS and 191 who underwent RS. No significant statistical differences were found between the two groups in terms of surgical and survival outcomes. 188 were analyzed after PSMA (94 patients in the LS group were matched with 94 patients in the RS group). The median estimated blood loss was higher in the LS group (p=0.001) and the median operative time was higher in the RS group (p=0.0003). No differences emerged between LS and RS in terms of disease free survival (DFS) (p=0.890) and overall survival (OS) (p=0.683). Our study showed that when compared LS and RS, RS showed lower blood losses and higher operative times. However, none of the two approaches demonstrated to be superior in terms of survival outcomes. For this reason, each patient should be evaluated individually to determine the best surgical approach.

Identifiants

pubmed: 34631553
doi: 10.3389/fonc.2021.724886
pmc: PMC8493293
doi:

Types de publication

Journal Article

Langues

eng

Pagination

724886

Informations de copyright

Copyright © 2021 Corrado, Vizza, Perrone, Mereu, Cela, Legge, Hilaris, Pasciuto, D’Indinosante, La Fera, Certelli, Bruno, Kogeorgos, Fanfani, De Iaco, Scambia and Gallotta.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Gynecol Oncol. 2016 May;141(2):211-217
pubmed: 26920107
Int J Gynecol Cancer. 2017 May;27(4):730-737
pubmed: 28399028
Curr Pharm Des. 2015;21(13):1699-705
pubmed: 25633116
Eur J Surg Oncol. 2017 Apr;43(4):703-709
pubmed: 27955835
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Anesthesiology. 2019 Jul;131(1):58-73
pubmed: 30882475
J Clin Oncol. 2009 Nov 10;27(32):5331-6
pubmed: 19805679
Cancer Chemother Rep. 1966 Mar;50(3):163-70
pubmed: 5910392
Gynecol Oncol. 2014 Jun;133(3):556-62
pubmed: 24708920
Stat Sci. 2010 Feb 1;25(1):1-21
pubmed: 20871802
Multivariate Behav Res. 2011 May;46(3):399-424
pubmed: 21818162
Int J Gynaecol Obstet. 2009 May;105(2):103-4
pubmed: 19367689
Eur Heart J. 2011 Jul;32(14):1704-8
pubmed: 21362706
Menopause. 2018 Sep;25(9):968-976
pubmed: 29762198
J Indian Med Assoc. 2009 Jun;107(6):403-5
pubmed: 19886379
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Stat Med. 2009 Nov 10;28(25):3083-107
pubmed: 19757444
J Robot Surg. 2010 Aug;4(2):109-15
pubmed: 27628776
Am J Obstet Gynecol. 2019 Mar;220(3):253.e1-253.e7
pubmed: 30557552
Control Clin Trials. 1996 Aug;17(4):343-6
pubmed: 8889347
Am J Obstet Gynecol. 2018 Jan;218(1):109.e1-109.e11
pubmed: 29037481
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
J Laparoendosc Adv Surg Tech A. 2018 Nov;28(11):1334-1345
pubmed: 29851362
Int J Gynecol Cancer. 2018 May;28(4):692-699
pubmed: 29557825
J Minim Invasive Gynecol. 2018 Jul - Aug;25(5):872-877
pubmed: 29339300
Am J Obstet Gynecol. 2016 Mar;214(3):350.e1-350.e10
pubmed: 26433173
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Ann Surg Oncol. 2020 Oct;27(10):3772-3780
pubmed: 32328983
Eur J Gynaecol Oncol. 2012;33(4):376-81
pubmed: 23091894
Int J Gynecol Cancer. 2010 Nov;20(8):1367-73
pubmed: 21051979

Auteurs

Giacomo Corrado (G)

Dipartimento Scienze della Salute della Donna, del Bambino, e di Sanità Pubblica, Ginecologia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Enrico Vizza (E)

Department of Experimental Clinical Oncology, Gynecologic Oncology Unit, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.

Anna Myriam Perrone (AM)

Division of Oncologic Gynaecology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Bologna, Italy.

Liliana Mereu (L)

Obstetrics and Gynecological Department, Santa Chiara Hospital, Trento, Italy.

Vito Cela (V)

Department of Obstetrics and Gynecology, University of Pisa, Pisa, Italy.

Francesco Legge (F)

Department of Obstetrics and Gynecology, Division of Gynecology, "F. Miulli" General Hospital, Bari, Italy.

Georgios Hilaris (G)

2nd Department of Gynecologic Oncology, Hygeia Hospital, Marousi, Athens, Greece.
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Stanford University Hospital, Stanford, CA, United States.

Tina Pasciuto (T)

Research Core Facilty Data Collection G-STeP, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

Marco D'Indinosante (M)

Dipartimento Scienze della Salute della Donna, del Bambino, e di Sanità Pubblica, Ginecologia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Eleonora La Fera (E)

Dipartimento Scienze della Salute della Donna, del Bambino, e di Sanità Pubblica, Ginecologia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Camilla Certelli (C)

Department of Experimental Clinical Oncology, Gynecologic Oncology Unit, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.

Valentina Bruno (V)

Department of Experimental Clinical Oncology, Gynecologic Oncology Unit, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.

Stylianos Kogeorgos (S)

2nd Department of Gynecologic Oncology, Hygeia Hospital, Marousi, Athens, Greece.

Francesco Fanfani (F)

Research Core Facilty Data Collection G-STeP, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

Pierandrea De Iaco (P)

Division of Oncologic Gynaecology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Bologna, Italy.

Giovanni Scambia (G)

Dipartimento Scienze della Salute della Donna, del Bambino, e di Sanità Pubblica, Ginecologia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Dipartimento Scienze della Salute della Donna, del Bambino, e di Sanità Pubblica, Ginecologia Oncologica, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Valerio Gallotta (V)

Dipartimento Scienze della Salute della Donna, del Bambino, e di Sanità Pubblica, Ginecologia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Classifications MeSH